New Guidance Outlining Total Artificial Disc Trial Design Issued
This article was originally published in The Gray Sheet
Executive Summary
Investigational device exemption applications for total artificial disc systems should include plans for product durability testing and multi-center clinical trials with at least two years of follow-up, according to new FDA guidance
You may also be interested in...
Globus Medical Preps IPO, Sales Force Ramp Ahead Of Artificial Cervical Disc Approval
Firm files for initial public stock offering, awaits PMA approval of its Secure-C artificial cervical disc.
Orthofix Set To Accelerate Advent Cervical Disc Trial Enrollment In Early 2009
Orthofix plans to accelerate a clinical study of its Advent artificial cervical disc in early 2009, the firm said during its first investor day Sept. 8 in New York
Orthofix Set To Accelerate Advent Cervical Disc Trial Enrollment In Early 2009
Orthofix plans to accelerate a clinical study of its Advent artificial cervical disc in early 2009, the firm said during its first investor day Sept. 8 in New York